| |||||||||
Type Mutant Strain; Transgenic; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Species laboratory mouse Generation N?+17p (23-MAY-04) Donating Investigator Thomas O'Brien, The Lankenau Medical Research Center Appearance
black, hairless
Related Genotype: a/aTgN(K6ODCtr)55Tgo/-Description
Mice carrying the (K6ODCtr)transgene show skin abnormalities including: alopecia, enhanced nail growth, follicular cysts in the dermis, excessive skin wrinkling and folding, oily skin, acne, and spontaneous squamous skin tumors. This strain may serve as a model for acne or for enhanced susceptibility to skin cancer. Mice homozygous for this transgene are not viable.Development
The transgene consists of a mutant murine Odc gene with a premature stop codon at position 427, and the minimal promoter from the bovine keratin 6 gene homolog. This strain was developed in the laboratory of Dr. Thomas O'Brien at The Lankenau Medical Research Center.
| Control | ||
|---|---|---|
| Noncarrier | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
View Related Disease (OMIM) Terms
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Tg(K6ODCtr)55Tgo/0
C57BL/6-Tg(K6ODCtr)55Tgo/J
- skin/coat/nails phenotype
- abnormal hair follicle morphology (MGI Ref ID J:62356)
- mice exhibit a dilatation of the hair follicle infundibulum and disintegration of the lower portion of the hair follicle
- abnormal nail morphology (MGI Ref ID J:62356)
- mice exhibit excessive nail growth
- alopecia (MGI Ref ID J:62356)
- by 1.5 months of age, mice exhibit generalized hair loss
- cysts replace the lower portion of the hair follicle
- dermal cysts (MGI Ref ID J:62356)
- cysts replace the lower portion of the hair follicle
- some cysts have thick walls of stratified squamous epithelium filled with concentrically oriented cornified squames
- in older mice, dermal cysts replace the subcutaneous fat layer
- some cysts rupture and form foreign body granulomas
- enlarged sebaceous gland (MGI Ref ID J:62356)
- sebaceous glands are moderately hyperplastic
- skin lesions (MGI Ref ID J:62356)
- mice exhibit comedo-like structures associated with sebaceous glands
- wrinkled skin (MGI Ref ID J:62356)
- as mice age their skin exhibits excessive growth resulting in wrinkling and folding
- touch/vibrissae phenotype
- absent vibrissae (MGI Ref ID J:62356)
- by 1.5 months of age
- adipose tissue phenotype
- decreased subcutaneous adipose tissue amount (MGI Ref ID J:62356)
- in older mice, dermal cysts replace the subcutaneous fat layer
- growth/size phenotype
- decreased body weight (MGI Ref ID J:62356)
- at birth
- endocrine/exocrine gland phenotype
- enlarged sebaceous gland (MGI Ref ID J:62356)
- sebaceous glands are moderately hyperplastic
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Tg(K6ODCtr)55Tgo/0
involves: C3H * C57BL/6
- skin/coat/nails phenotype
- abnormal nail morphology (MGI Ref ID J:29098)
- mice exhibit excessive nail growth
- absent hair follicles (MGI Ref ID J:29098)
- after 2 months of age
- alopecia (MGI Ref ID J:29098)
- despite a normal first hair cycle, mice exhibit hair loss at 2 to 3 weeks of age
- mice exhibit complete hair loss by 2 months of age
- hair loss is a dominant phenotype
- dermal cysts (MGI Ref ID J:29098)
- mice exhibit follicular cysts in the dermis
- in mice older than 3 months, cysts are very large and replace the subcutaneous fat layer
- enlarged sebaceous gland (MGI Ref ID J:29098)
- sebaceous glands near dermal cysts are moderately hyperplastic
- oily skin (MGI Ref ID J:29098)
- develops with age
- skin lesions (MGI Ref ID J:29098)
- mice develop keratoacanthom-like lesions
- skin tumor (MGI Ref ID J:29098)
- mice develop skin tumors (squamous neoplasms) at a higher rate than wild-type mice
- however, squamous cell carcinomas are not observed
- skin papilloma (MGI Ref ID J:29098)
- mice develop keratoacanthom-like lesions and well-differentiated papillomatous lesions
- skin tumors are found on the tail, face and ears
- wrinkled skin (MGI Ref ID J:29098)
- develops with age
- adipose tissue phenotype
- decreased subcutaneous adipose tissue amount (MGI Ref ID J:29098)
- after three months of age, dermal cysts replace the subcutaneous fat layer
- touch/vibrissae phenotype
- absent vibrissae (MGI Ref ID J:29098)
- by 2 months of age
- growth/size phenotype
- decreased body weight (MGI Ref ID J:29098)
- at birth
- cellular phenotype
- increased apoptosis (MGI Ref ID J:133302)
- in culture, primary keratinocytes undergo premature cell death via apoptosis compared to wild-type cells
- increased cell density prolongs primary keratinocyte cell life in culture but does not prevent premature death
- however, treatment with DFMO blocks cell death in cultured primary keratinocytes
- tumorigenesis
- skin tumor (MGI Ref ID J:29098)
- mice develop skin tumors (squamous neoplasms) at a higher rate than wild-type mice
- however, squamous cell carcinomas are not observed
- skin papilloma (MGI Ref ID J:29098)
- mice develop keratoacanthom-like lesions and well-differentiated papillomatous lesions
- skin tumors are found on the tail, face and ears
- endocrine/exocrine gland phenotype
- enlarged sebaceous gland (MGI Ref ID J:29098)
- sebaceous glands near dermal cysts are moderately hyperplastic
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Odc1 related
Cancer Research
Increased Tumor Incidence (Skin Cancers)
Toxicology
Dermatology Research
Skin and Hair Texture Defects
Metabolism Research
Research Tools
Cancer Research
Dermatology Research
Toxicology Research
| Allele Symbol | Tg(K6ODCtr)55Tgo | ||
|---|---|---|---|
| Allele Name | transgene insertion 55, Thomas O'Brien | ||
| Allele Type | Transgenic (random, expressed) | ||
| Common Name(s) | K6/ODC; | ||
| Mutation Made By | Thomas O'Brien, The Lankenau Medical Research Center | ||
| Strain of Origin | (C57BL/6 x C3H)F2 | ||
| Expressed Gene | Odc1, ornithine decarboxylase, structural 1, mouse, laboratory | ||
| Promoter | KRT6, keratin 6A, cattle | ||
| Molecular Note | The transgene consists of a mutant murine Odc1 gene with a premature stop codon at position 427, and the minimal promoter from the bovine keratin 6 gene homolog. | ||
Genotyping Protocols
Tg(K6ODCtr)55Tgo, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Megosh L; Gilmour SK; Rosson D; Soler AP; Blessing M; Sawicki JA; O'Brien TG. 1995. Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Res 55(19):4205-9. [PubMed: 7671221] [MGI Ref ID J:29098]
Morikawa T; Wanibuchi H; Morimura K; Ogawa M; Fukushima S. 2000. Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice. Jpn J Cancer Res 91(6):579-81. [PubMed: 10874208] [MGI Ref ID J:62952]
Tg(K6ODCtr)55Tgo relatedChen Y; Megosh LC; Gilmour SK; Sawicki JA; O'Brien TG. 2000. K6/ODC transgenic mice as a sensitive model for carcinogen identification. Toxicol Lett 116(1-2):27-35. [PubMed: 10906419] [MGI Ref ID J:63568]
George K; Iacobucci A; Uitto J; O'brien TG. 2005. Identification of an X-linked locus modifying mouse skin tumor susceptibility. Mol Carcinog 44(3):212-8. [PubMed: 16086382] [MGI Ref ID J:101472]
Gilmour SK; Birchler M; Smith MK; Rayca K; Mostochuk J. 1999. Effect of elevated levels of ornithine decarboxylase on cell cycle progression in skin. Cell Growth Differ 10(11):739-48. [PubMed: 10593650] [MGI Ref ID J:59581]
Hobbs CA; Wei G; Defeo K; Paul B; Hayes CS; Gilmour SK. 2006. Tip60 Protein Isoforms and Altered Function in Skin and Tumors that Overexpress Ornithine Decarboxylase. Cancer Res 66(16):8116-22. [PubMed: 16912189] [MGI Ref ID J:113386]
Lan L; Trempus C; Gilmour SK. 2000. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice Cancer Res 60(20):5696-703. [PubMed: 11059762] [MGI Ref ID J:65347]
Megosh L; Halpern M; Farkash E; O'Brien TG. 1998. Analysis of ras gene mutational spectra in epidermal papillomas from K6/ODC transgenic mice. Mol Carcinog 22(3):145-9. [PubMed: 9688139] [MGI Ref ID J:49929]
Miller TJ; Honchel R; Espandiari P; Knapton A; Zhang J; Sistare FD; Hanig JP. 2008. The utility of the K6/ODC transgenic mouse as an alternative short term dermal model for carcinogenicity testing of pharmaceuticals. Regul Toxicol Pharmacol 50(1):87-97. [PubMed: 18069108] [MGI Ref ID J:133428]
Morikawa T; Wanibuchi H; Morimura K; Ogawa M; Fukushima S. 2000. Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice. Jpn J Cancer Res 91(6):579-81. [PubMed: 10874208] [MGI Ref ID J:62952]
O'Brien TG; Megosh LC; Gilliard G; Soler AP. 1997. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res 57(13):2630-7. [PubMed: 9205069] [MGI Ref ID J:41488]
Panteleyev AA; Christiano AM; O'Brien TG; Sundberg JP. 2000. Ornithine decarboxylase transgenic mice as a model for human atrichia with papular lesions Exp Dermatol 9(2):146-51. [PubMed: 10772389] [MGI Ref ID J:62356]
Peralta Soler A; Gilliard G; Megosh L; George K; O'Brien TG. 1998. Polyamines regulate expression of the neoplastic phenotype in mouse skin. Cancer Res 58(8):1654-9. [PubMed: 9563478] [MGI Ref ID J:47024]
Smith MK; Trempus CS; Gilmour SK. 1998. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin. Carcinogenesis 19(8):1409-15. [PubMed: 9744537] [MGI Ref ID J:50136]
Tang X; Kim AL; Feith DJ; Pegg AE; Russo J; Zhang H; Aszterbaum M; Kopelovich L; Epstein EH Jr; Bickers DR; Athar M. 2004. Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice. J Clin Invest 113(6):867-75. [PubMed: 15067319] [MGI Ref ID J:89218]
Wei G; DeFeo K; Hayes CS; Woster PM; Mandik-Nayak L; Gilmour SK. 2008. Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes. Cancer Res 68(7):2214-22. [PubMed: 18381427] [MGI Ref ID J:133302]
Colony Maintenance
Breeding & Husbandry This strain was generated on a mixed C57BL/6 x C3H background. It has been backcrossed 5 times to C57BL/6J and is maintained by mating hemizygous males to normal wildtype females. Expected coat color from breeding:Black and Hairless Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $1900.00 Cryopreserved Embryos Fee $1600.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Pricing for International shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $2470.00 Cryopreserved Embryos Fee $2080.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Standard Supply | Cryopreserved. Ready for recovery. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Noncarrier | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.